How does atrial tachycardia cause supraventricular tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atrial Tachycardia Does Not "Cause" SVT—It IS a Type of SVT

Atrial tachycardia (AT) is a specific subtype of supraventricular tachycardia, not a cause of it. SVT is an umbrella term encompassing multiple distinct arrhythmias that originate from tissue at or above the His bundle, and AT represents one category within this broader classification 1, 2.

Understanding the Taxonomic Relationship

SVT is defined as any tachycardia exceeding 100 bpm at rest where the mechanism involves tissue from the His bundle or above 1, 2. This umbrella term includes:

  • Atrial tachycardias (focal AT, multifocal AT, macroreentrant AT including atrial flutter) 1, 3
  • Atrioventricular nodal reentrant tachycardia (AVNRT) - the most common form of paroxysmal SVT 4, 3
  • Atrioventricular reentrant tachycardia (AVRT) - requiring an accessory pathway 1, 3
  • Junctional tachycardias 3

Focal Atrial Tachycardia Characteristics

Focal AT arises from a localized atrial site with regular, organized atrial activity characterized by discrete P waves with typically an isoelectric segment between P waves 1, 2. Key distinguishing features include:

  • Atrial rates typically between 100-250 bpm, rarely reaching 300 bpm 1
  • Neither the sinus node nor AV node plays a role in initiation or perpetuation 1
  • P waves generally occur in the second half of the tachycardia cycle, often obscured by the preceding T wave 1
  • The presence of AV block during tachycardia excludes AVRT and makes AVNRT very unlikely, helping confirm AT as the diagnosis 1

Mechanisms of Focal AT

Focal AT can result from three distinct electrophysiologic mechanisms: abnormal automaticity, triggered activity (delayed afterdepolarization), or microreentry 1. Clinical clues to mechanism include:

  • "Warm-up" (progressive rate increase at onset) and "cool-down" (progressive rate decrease before termination) suggest automatic mechanism 1
  • Automatic ATs tend to be incessant, especially in children 1
  • Triggered activity ATs may be either incessant or paroxysmal 1

Anatomic Distribution

Focal ATs cluster in specific anatomical zones rather than occurring randomly 1:

  • Right-sided ATs predominantly originate along the crista terminalis from the sinoatrial node to the AV node 1
  • Left atrial foci commonly arise from pulmonary veins, atrial septum, or mitral annulus 1
  • Many left atrial foci serve as generators for atrial fibrillation 1

Clinical Significance

Focal AT is diagnosed in only 10-15% of patients referred for catheter ablation of SVT, making it relatively uncommon 1. The prevalence is:

  • 0.34% in asymptomatic patients 1
  • 0.46% in symptomatic patients 1

The outlook is usually benign except for incessant forms, which may lead to tachycardia-induced cardiomyopathy—a critical complication affecting morbidity and quality of life 1, 5.

Common Pitfall: Drug-Induced AT

Digitalis is the drug most commonly associated with focal AT, typically presenting as AT with AV block 1. This presentation is distinctive because:

  • The ventricular rate is not excessively rapid due to AV block 1
  • Hypokalemia may exacerbate the arrhythmia 1
  • Treatment consists of discontinuing digitalis; in cases of persistent advanced AV block, digitalis-binding agents should be considered 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Atrial Tachycardia and Supraventricular Tachycardia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Classification of Supraventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Supraventricular Tachycardia Types and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Dilated cardiomyopathy secondary to atrial ectopic tachycardia].

Anales de pediatria (Barcelona, Spain : 2003), 2006

Related Questions

How do I discuss supraventricular tachycardia (SVT) monitor results with a patient over the phone?
What is the pathophysiology and management of Supraventricular Tachycardia (SVT)?
Can Supraventricular Tachycardia (SVT) have a P wave?
What are the next steps for a 50-year-old patient with fatigue and palpitations, normal heart rhythm, and a 7-day Holter monitor showing a single episode of Supraventricular Tachycardia lasting 7 beats?
What is the next most appropriate step in managing a 26-year-old patient with supraventricular tachycardia (SVT) and tachycardia, after unsuccessful vagal maneuvers, between cardioversion, diltiazem (Diltiazem), or esmolol (Esmolol)?
What is the recommended total daily dose of sucralfate for an adult with peptic ulcer disease and for stress‑ulcer prophylaxis in critically ill patients?
What is the appropriate order for a nicardipine intravenous infusion (16 µg/mL) to manage acute hypertension in a 70‑kg adult with hypertensive emergency (e.g., severe intracerebral hemorrhage)?
How should I perform continuous bladder irrigation for a patient with chronic radiation cystitis and persistent brisk hematuria refractory to simple catheter drainage?
In an otherwise healthy adult with bilateral concha lamella (middle turbinate variant) and no nasal symptoms, what is the recommended management?
In a 28-year-old man with chronic cervical tetraplegia who is being weaned from mechanical ventilation and requires a sleep‑promoting sedative, does dexmedetomidine significantly interfere with enteral nutrition?
Which finding favors an exudative pleural effusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.